Sue Chan

672 total citations
21 papers, 564 citations indexed

About

Sue Chan is a scholar working on Molecular Biology, Surgery and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sue Chan has authored 21 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 7 papers in Surgery and 6 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sue Chan's work include Pancreatic function and diabetes (7 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Sue Chan is often cited by papers focused on Pancreatic function and diabetes (7 papers), Ion channel regulation and function (6 papers) and Receptor Mechanisms and Signaling (4 papers). Sue Chan collaborates with scholars based in United Kingdom, United States and Sweden. Sue Chan's co-authors include Noel G. Morgan, Jeffrey R. Fry, Margaret K. Pratten, Christopher A. Ramsden, Jenni Harvey, Andrew J. Irving, S P H Alexander, Stanley G. Schultz, Klaus Turnheim and James Costantin and has published in prestigious journals such as Diabetes, Biochemical and Biophysical Research Communications and FEBS Letters.

In The Last Decade

Sue Chan

20 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sue Chan United Kingdom 12 269 141 131 104 69 21 564
Makoto Muramatsu Japan 14 261 1.0× 92 0.7× 126 1.0× 90 0.9× 58 0.8× 46 611
Madeleine Picq France 15 315 1.2× 73 0.5× 50 0.4× 50 0.5× 105 1.5× 30 699
Mohaddeseh Sadat Alavi Iran 15 192 0.7× 42 0.3× 121 0.9× 130 1.3× 81 1.2× 44 611
Huiyong Huang China 18 357 1.3× 59 0.4× 45 0.3× 79 0.8× 55 0.8× 42 766
Jitendriya Mishra India 15 204 0.8× 40 0.3× 193 1.5× 89 0.9× 102 1.5× 18 661
Jacqueline Alves Leite Brazil 15 280 1.0× 48 0.3× 72 0.5× 67 0.6× 74 1.1× 27 751
Tomonori Kurokáwa Japan 15 382 1.4× 43 0.3× 79 0.6× 39 0.4× 109 1.6× 35 635
Xian‐Zhe Dong China 19 327 1.2× 61 0.4× 62 0.5× 93 0.9× 69 1.0× 60 800
Shinichi Uchida Japan 13 228 0.8× 33 0.2× 71 0.5× 54 0.5× 137 2.0× 23 623
Hwa‐Young Lee South Korea 15 221 0.8× 31 0.2× 118 0.9× 90 0.9× 86 1.2× 35 670

Countries citing papers authored by Sue Chan

Since Specialization
Citations

This map shows the geographic impact of Sue Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Chan more than expected).

Fields of papers citing papers by Sue Chan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Chan. The network helps show where Sue Chan may publish in the future.

Co-authorship network of co-authors of Sue Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Chan. A scholar is included among the top collaborators of Sue Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Chan. Sue Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olofsson, Charlotta S., et al.. (2019). CaV1.2 and CaV1.3 voltage-gated L-type Ca2+ channels in rat white fat adipocytes. Journal of Endocrinology. 244(2). 369–381. 10 indexed citations
2.
Irving, Andrew J., et al.. (2017). Cannabinoid Receptor-Related Orphan G Protein-Coupled Receptors. Advances in pharmacology. 80. 223–247. 61 indexed citations
4.
Chan, Sue, et al.. (2014). Etiology of the membrane potential of rat white fat adipocytes. American Journal of Physiology-Endocrinology and Metabolism. 307(2). E161–E175. 17 indexed citations
5.
Chan, Sue, et al.. (2013). Investigation of the functional expression of purine and pyrimidine receptors in porcine isolated pancreatic arteries. Purinergic Signalling. 10(2). 241–249. 5 indexed citations
6.
Latif, M.L., et al.. (2013). Novel vasocontractile role of theP2Y14receptor: characterization of its signalling in porcine isolated pancreatic arteries. British Journal of Pharmacology. 171(3). 701–713. 23 indexed citations
7.
Selco, Jodye I., Mary Bruno, & Sue Chan. (2013). Discovering Periodicity: Hands-On, Minds-On Organization of the Periodic Table by Visualizing the Unseen. Journal of Chemical Education. 90(8). 995–1002. 8 indexed citations
9.
Taylor, James P., et al.. (2006). Rhes expression in pancreatic β-cells is regulated by efaroxan in a calcium-dependent process. Biochemical and Biophysical Research Communications. 349(2). 809–815. 7 indexed citations
10.
Morgan, Noel G. & Sue Chan. (2004). Imidazoline Receptors and their Ligands as Potentiators of Nutrient-Induced Insulin Secretion. 1(3). 185–193. 2 indexed citations
11.
Chan, Sue, et al.. (2002). Identification of the monomeric G‐protein, Rhes, as an efaroxan‐regulated protein in the pancreatic β‐cell. British Journal of Pharmacology. 136(1). 31–36. 16 indexed citations
12.
Dunn, William, et al.. (2001). Evidence for a non‐adrenoceptor, imidazoline‐mediated contractile response to oxymetazoline in the porcine isolated rectal artery. British Journal of Pharmacology. 132(7). 1359–1363. 8 indexed citations
13.
Morgan, Noel G. & Sue Chan. (2001). Imidazoline Binding Sites in the Endocrine Pancreas: Can They Fulfil Their Potential as Targets for the Development of New Insulin Secretagogues?. Current Pharmaceutical Design. 7(14). 1413–1431. 56 indexed citations
14.
Chan, Sue, et al.. (2001). Characterization of a KATP Channel—Independent Pathway Involved in Potentiation of Insulin Secretion by Efaroxan. Diabetes. 50(2). 340–347. 33 indexed citations
15.
Chan, Sue, et al.. (1999). Multiple effector pathways regulate the insulin secretory response to the imidazoline RX871024 in isolated rat pancreatic islets. British Journal of Pharmacology. 127(5). 1279–1287. 15 indexed citations
16.
Morgan, Noel G., et al.. (1999). Imidazolines and Pancreatic Hormone Secretiona. Annals of the New York Academy of Sciences. 881(1). 217–228. 54 indexed citations
17.
Cosgrove, Karen E., et al.. (1999). Affinity isolation of imidazoline binding proteins from rat brain using 5‐amino‐efaroxan as a ligand. FEBS Letters. 447(1). 61–64. 27 indexed citations
18.
Chan, Sue, Hazel C. Cable, Roger F.L. James, et al.. (1996). Expression of α2- and β-adrenoceptor subtypes in human islets of Langerhans. Journal of Endocrinology. 148(3). 531–543. 29 indexed citations
19.
Mendelsohn, F. A. O., et al.. (1994). Strychnine-binding proteins in intestinal cells: novel brucine binding site with binding affinities for alkaloids.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 1074–1079. 1 indexed citations
20.
Turnheim, Klaus, James Costantin, Sue Chan, & Stanley G. Schultz. (1989). Reconstitution of a calcium-activated potassium channel in basolateral membranes of rabbit colonocytes into planar lipid bilayers. The Journal of Membrane Biology. 112(3). 247–254. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026